Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950159-13-000329
Filing Date
2013-05-15
Accepted
2013-05-15 10:10:40
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 TENGION, INC. FORM 10-Q tengion10q.htm 10-Q 1445088
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15966
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16107
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8745
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8815
  Complete submission text file 0000950159-13-000329.txt   7571851

Data Files

Seq Description Document Type Size
6 tngn-20130331.xml EX-101.INS 1229759
7 tngn-20130331.xsd EX-101.SCH 54427
8 tngn-20130331_cal.xml EX-101.CAL 43498
9 tngn-20130331_def.xml EX-101.DEF 220756
10 tngn-20130331_lab.xml EX-101.LAB 703703
11 tngn-20130331_pre.xml EX-101.PRE 362538
Mailing Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103
Business Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103 336-722-5855
TENGION INC (Filer) CIK: 0001296391 (see all company filings)

EIN.: 200214813 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34688 | Film No.: 13844266
SIC: 2836 Biological Products, (No Diagnostic Substances)